Literature DB >> 19541885

2009 European (IUSTI/WHO) guideline on the diagnosis and treatment of gonorrhoea in adults.

C Bignell1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19541885     DOI: 10.1258/ijsa.2009.009160

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


× No keyword cloud information.
  19 in total

Review 1.  Periurethral abscess complicating gonococcal urethritis: case report and literature review.

Authors:  A Kenfak-Foguena; Y Zarkik; M Wisard; V Praz; K E A Darling; K Jaton-Ogay; P Jichlinski; M Cavassini
Journal:  Infection       Date:  2010-09-03       Impact factor: 3.553

Review 2.  The use of cephalosporins for gonorrhea: an update on the rising problem of resistance.

Authors:  Juliet E Stoltey; Pennan M Barry
Journal:  Expert Opin Pharmacother       Date:  2012-05-30       Impact factor: 3.889

3.  Clonally related Neisseria gonorrhoeae isolates with decreased susceptibility to the extended-spectrum cephalosporin cefotaxime in Amsterdam, the Netherlands.

Authors:  Raymond Heymans; Sylvia M Bruisten; Daniel Golparian; Magnus Unemo; Henry J C de Vries; Alje P van Dam
Journal:  Antimicrob Agents Chemother       Date:  2012-01-03       Impact factor: 5.191

Review 4.  Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea.

Authors:  Magnus Unemo; Robert A Nicholas
Journal:  Future Microbiol       Date:  2012-12       Impact factor: 3.165

5.  Phenotypic and genotypic properties of Neisseria gonorrhoeae isolates in Norway in 2009: antimicrobial resistance warrants an immediate change in national management guidelines.

Authors:  S O Hjelmevoll; D Golparian; L Dedi; D H Skutlaberg; E Haarr; A Christensen; S Jørgensen; Ø J Nilsen; M Unemo; V Skogen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-09-30       Impact factor: 3.267

6.  Purification of DNA eluates from the ProbeTec GC Q(x) assay on BD Viper™ XTR allows for further analysis and confirmation of gonorrhea.

Authors:  H S Tunsjø; E Smedsrud; P C Holm; K Rokvam; C Schie; V Rognlien; I Augustin; A Fostervold
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-08-01       Impact factor: 3.267

Review 7.  Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example.

Authors:  A Dalhoff
Journal:  Infection       Date:  2012-03-30       Impact factor: 3.553

8.  Genome sequencing of a Neisseria gonorrhoeae isolate of a successful international clone with decreased susceptibility and resistance to extended-spectrum cephalosporins.

Authors:  David Hess; Abel Wu; Daniel Golparian; Sarah Esmaili; Will Pandori; Emilee Sena; Jeffrey D Klausner; Pennan Barry; Magnus Unemo; Mark Pandori
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

9.  Global fluoroquinolone resistance epidemiology and implictions for clinical use.

Authors:  Axel Dalhoff
Journal:  Interdiscip Perspect Infect Dis       Date:  2012-10-14

10.  Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from India, Pakistan and Bhutan in 2007-2011.

Authors:  Sunil Sethi; Daniel Golparian; Manju Bala; Dorji Dorji; Muhammad Ibrahim; Kausar Jabeen; Magnus Unemo
Journal:  BMC Infect Dis       Date:  2013-01-24       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.